Centre for Diabetes Research (CDR)


http://www.cdr.org.au
CDR Staff

Our work at the Centre for Diabetes Research is aimed at understanding and preventing diabetes and its complications.

Diabetes is recognized as a major public health problem and is Australia's fifth "national health priority area". It is characterized by increased blood sugar levels, and has two major forms: type 1 diabetes, which results from the body's own immune system destroying the insulin-producing cells; and type 2 diabetes, which results from the person's growing inability to respond normally to insulin. Both forms of diabetes are caused by complex interactions between many genes and environmental factors. Our particular focus is on the genetics of type 1 diabetes.

Our group is part of the world-wide Type 1 Diabetes Genetics Consortium, and is leading collaborative networks across Australia and the Asia-Pacific region in assembling resources to identify the genes which affect the risk of developing type 1 diabetes. We also study animal models of type 2 diabetes and diabetes complications. Our work has resulted in the identification of genes affecting each form of diabetes in both humans and mice. We are now investigating ways that we can restore the ability to produce insulin by developing stem cell treatments. Finally, we are also establishing state-of-the-art "systems genetics" technologies, which will integrate multiple levels of data with underlying genetic information, allowing the definition of networks of interacting genes.

The Centre for Diabetes Research gratefully acknowledges the support of the Diabetes Research Foundation.

What's New!

Fang-Xu JiangDr Fang-Xu Jiang

As an invited speaker, I presented our findings entitled "Differentiation of Islet Progenitor Ngn3-expressing cells into Insulin-secreting β Cells is Promoted by Inhibition of SIRT1" in the Stem Cells and Regenerative Medicine World Congress, South San Francisco, USA on 20th and 21st January 2010.

Grant MorahanA Collaboration Between the ACDDR and Sequenom

Samples from 1,000 families who have participated in the Australian Childhood Diabetes DNA Repository have been sent to Sequenom. Sequenom, who provide genetic analysis solutions, are testing the families for the 40 genes found by the T1DGC to be highly associated with diabetes. The ACDDR will allow us to determine if these 40 genes are relevant to the Australian population. For more information or to participate in the ACDDR please see our website.